Gibson Assembly
Gibson Assembly
NEB #E2611S/L
10/50 reactions
ISO 9001 ISO 14001 ISO 13485
Registered Registered Registered
Quality Environmental Medical Devices
Management Management
Limited Use Label License: The Gibson Assembly™ Master Mix, and components and products thereof, are to be used
for internal research purposes for the sole benefit of the purchaser only. They may not be used for any other purpose,
including, but not limited to, use in drugs, diagnostics, therapeutics or in humans. The Gibson Assembly Master Mix,
and components and products thereof, may not be transferred or sold to third parties, resold, modified for resale, or
used to manufacture commercial products or to provide a service of any kind to third parties, including without limita-
tion, reporting the results of purchaser’s activities for a fee or other form of consideration. For information on obtaining
additional rights, please contact Synthetic Genomics® at [email protected].
Limited Warranty: The Gibson Assembly Master Mix is warranted to perform according to specifications stated on the
certificate of analysis. No other warranty is made, whether express or implied, including any warranty of merchant-
ability or fitness for a particular purpose. This warranty limits NEB’s and its licensors’ liability to only the price of the kit.
Neither NEB nor its licensors shall have any responsibility or liability for any special, incidental, indirect or consequential
loss or damage whatsoever.
Additional Limited Use Label License is below:
The purchase of this product also conveys to the purchaser only the limited, non-transferable right to use the purchased
quantity of the product for the purchaser’s own research by the purchaser only under the following U.S. patent claims
and foreign counterpart patent claims: U.S. Patent No. 5,436,149 (claims 6-16). No rights are granted to the purchaser
to sell, modify for resale or otherwise transfer this product, either alone or as a component of another product, to any
third party. Takara Bio reserves all other rights, and this product may not be used in any manner other than as provided
herein. For information on obtaining a license to use this product for purposes other than research, please contact
Takara Bio Inc., Seta 3-4-1, Otsu, Shiga 520-2193, Japan (Fax +81-77-453-9254).
Table of Contents:
Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Specification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Overview of Gibson Assembly Master Mix Protocol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
Design and PCR Amplification of Fragments for Gibson Assembly . . . . . . . . . . . . . 3
Gibson Assembly Reaction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11
Chemically Competent Cells Transformation Protocol . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Electrocompetent Cells Transformation Protocol . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Usage Notes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13
Frequently Asked Questions (FAQs) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Troubleshooting . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 19
Ordering Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Components:
Store at –20°C. Thaw, vortex thoroughly before use and keep on ice.
1
Introduction:
Gibson Assembly was developed by Dr. Daniel Gibson and his colleagues at
the J. Craig Venter Institute and licensed to NEB by Synthetic Genomics, Inc. It
allows for successful assembly of multiple DNA fragments, regardless of frag-
ment length or end compatibility. It has been rapidly adopted by the synthetic
biology community due to its ease-of-use, flexibility and suitability for large DNA
constructs.
Gibson Assembly efficiently joins multiple overlapping DNA fragments in a
single-tube isothermal reaction (1,2). The Gibson Assembly Master Mix includes
three different enzymatic activities that perform in a single buffer:
• The exonuclease creates single-stranded 3´ overhangs that facilitate the
annealing of fragments that share complementarity at one end (overlap region).
• The proprietary polymerase fills in gaps within each annealed fragment.
• The DNA ligase seals nicks in the assembled DNA.
The end result is a double-stranded fully sealed DNA molecule that can serve
as template for PCR, RCA or a variety of other molecular biology applications,
including direct transformation. The method has been successfully used by Gib-
son’s group and others to assemble oligonucleotides, DNA with varied overlaps
(15–80 bp) and fragments hundreds of kilobases long (1–2).
Gibson Assembly
Add fragments to 3´
Gibson Assembly 5´
5´
Master Mix. 3´
5´ Exonuclease chews back 5´ ends.
3´
5´
5´
3´
A+B
Fully Assembled DNA
2
Specification:
10 µl of 2X Gibson Assembly Master Mix was incubated with 6 fragments
(5 fragments of 400 bp and one of 2,780 bp, with 40 bp overlap, 0.05 pmol
each) in a final volume of 20 µl at 50°C for 60 minutes. NEB 5-alpha Competent
E. coli (NEB #C2987) were transformed with 2 µl of the master mix/fragment
mixture using the transformation protocol on page 11. Greater than 100
white colonies were observed when 1/10 of the outgrowth was spread on an
ampicillin plate with IPTG/Xgal and incubated overnight.
IV. Design overlapping primers starting from the first 5´ nucleotide of the overlap region:
Primer FP1 Primer FP2 Primer FP3
V. Amplify Fragment 1 with primers FP1 + RP1, Fragment 2 with primers FP2 + RP2 and Fragment 3 with primers FP3 + RP3:
Figure 2B: Primer design for PCR-generated vector and insert using in silico
created final DNA sequence file.
I. Create a final sequence file displaying both DNA strands:
Vector Left Arm Insert Vector Right Arm
II. Mark the junctions between the vector and the insert:
GTTTAACTTTAAGAAGGAGATATACAT ATGACCATGATTACGGATTCACT...AGTTGGTCTGGTGTCAAAAATAA TGAGATCCGGCTGCTAACAAAGCCCGAAA
CAAATTGAAATTCTTCCTCTATATGTA TACTGGTACTAATGCCTAAGTGA...TCAACCAGACCAGAGTTTTTATT ACTCTAGGCCGACGATTGTTTCGGGCTTT
IV. Design overlapping primers starting from the first 5´ nucleotide of the overlap region:
Primer FP1 Primer FP2
V. Amplify Insert with primers FP1 + RP1 and Vector with primers FP2 + RP2:
Vector Left Arm Vector Right Arm
Overlap Overlap
GTTTAACTTTAAGAAGGAGATATACAT ATGACC TGAGATCCGGCTGCTAACAAAGCCCGAAA
CAAATTGAAATTCTTCCTCTATATGTA TACTGG ACTCTAGGCCGACGATTGTTTCGGGCTTT
GGAGATATACAT ATGACCATGATTACGGATTCACT...AGTTGGTCTGGTGTCAAAAATAA TGAGATCCGGCTGCT
CCTCTATATGTA TACTGGTACTAATGCCTAAGTGA...TCAACCAGACCAGAGTTTTTATT ACTCTAGGCCGACGA
Insert
5
Primer Design for PCR-Generated Vector and Insert
For the purposes of primer design, the vector and the insert may be viewed as
two PCR fragments that have to be assembled into a circular DNA molecule.
This means that the primer design rules described above may also be applied
for generation of the vector fragment and the insert fragment sharing overlap-
ping ends. Use the in silico-created final sequence file as a template to design
overlapping primers between the vector and the insert by accomplishing the
same steps as described above, as shown in Figure 2B.
If you intend to use PCR-generated vector for one specific insertion, then the
overlap sequence may be split between the vector and the insert in any combi-
nation to make shorter primers (Figure 2B, step III, overlap shown in orange).
However, if the same PCR-generated vector will be used for assembly of vari-
ous inserts, then the entire overlap sequence must originate from the vector
sequence and must be added to primers that will be used to amplify the insert
(Figure 2B, step III, overlap shown in blue). The latter case is also illustrated
in Figure 3 for assembly of the lacZ gene into a pET21a vector. The pET21a
forward primer (orange arrow) and the reverse primer (blue arrow) start at
the position where the lacZ gene must be inserted. Both vector-specific prim-
ers completely match the vector sequence on the respective strands marked
in orange and blue. This inverse PCR strategy yields a linear vector fragment.
Generally, 10–100 pg of a vector is recommended as a template in the inverse
PCR reaction.
To amplify the lacZ gene, both forward and reverse lacZ-specific priming
sequences (gray) at their 5´ end are fused with 20-nt vector sequences to be
used as overlap sequences in assembly with the vector. Within the lacZ Forward
PCR primer, the overlap sequence (orange) is identical to the 20-nt terminal
sequence on the top strand (orange) of the vector’s left-arm (in the 5´→3´
direction). Within the lacZ Reverse PCR primer, the overlap sequence (blue) is
identical to the 21-nt terminal sequence on the bottom strand (blue) of the vec-
tor’s right-arm (in the 5´→3´ direction). The length of the overlap sequence is
determined by the number of nucleotides needed to reach a Tm ≥ 48°C. If nec-
essary, one may add additional nucleotides between the overlap sequence and
the lacZ-specific sequence, for example, to introduce a unique restriction site.
6
Figure 3: Primer Design for Vector pET21a and lacZ Gene Assembly.
5´-ATTTTGTTTAACTTTAAGAAGGAGATATACAT-3´ TGAGATCCGGCTGCTAACAAAG-3´
3´-TAAAACAAATTGAAATTCTTCCTCTATATGTA-5´ ACTCTAGGCCGACGATTGTTTC-5´
5´-TTTAAGAAGGAGATATACATATGACCATGATTACGGATTC
lacZ Gene
TCAACCAGACCACAGTTTTTACTCTAGGCCGACGATTGTTT- 5´
7
Primer Design for Assembly of Restriction Enzyme Digested Vector and
PCR-Generated Insert.
Restriction enzyme-treated vectors can have 5´-overhangs, 3´-overhangs or
blunt ends. When vector is linearized by restriction digestion, the entire over-
lap sequence must originate from the vector sequence and must be added
to primers that will be used to amplify the insert. The overlap region of the
forward primer for the gene of interest (orange) should line up with the 3´
end of the overhang on the vector’s left arm and extend back until the Tm ≥
48°C (Fig.4A, Left side). This primer also includes gene-specific sequence at
the 3´-end (gray). Keep in mind that the restriction site, which was used to
digest the vector, will be lost in the assembled product. However, additional
nucleotides may be added between the overlap region and gene-specific
sequence region to restore the pre-existing restriction site, or to introduce a
new, unique restriction site. A similar principle is applied to the design of the
reverse primer for the gene of interest (Fig. 4A, Right side).
5´ Overhang 5´ Overhang
Restriction Enzyme Digested Vector
3´ Overhang 3´ Overhang
Overlap Region (≥16 nt) -3´
Gene of Interest 5´-
-5´ 3´- Overlap Region (≥16 nt)
Blunt-end Blunt-end
Overlap Region (≥16 nt) -3´ 5´-
-5´ 3´- Overlap Region (≥16 nt)
Figure 4B shows primer design for assembly of the lacZ gene and pMAL-c5X,
digested with NcoI and SbfI. In this example, the forward primer of the gene
has a "C" nucleotide (underlined) inserted between the 18-nt overlap and the
N-terminal sequence of the lacZ gene to ensure the lacZ protein is in frame
with the maltose binding protein.
8
Figure 4B: Primer Design for lacZ Gene and NcoI/SbfI-cut pMAL-c5X
Assembly
lacZ Gene Forward PCR Primer
18-nt Overlap Region N-terminal Sequence of lacZ Gene
5´-AAGGATTTCACATATGTCCATGACCATGATTACGGATTC
5´-GGAAGGATTTCACATATGTC-3´ 5´-GGTAATTAAATAAGCTTC-3´
3´-CCTTCCTAAAGTGTATACAGGTAC-5´
lacZ gene 3´-ACGTCCATTAATTTATTCGAAG-5´
TCAACCAGACCACAGTTTTTACTACGTCCATTAATTTATTCGA- 5´
9
Useful Recommendations for PCR Amplification
NEB recommends using Q5 High-Fidelity DNA polymerase (NEB #M0491)
or related products (NEB #M0493 or NEB #M0494) to amplify fragments
of interest prior to assembly. The use of this high-fidelity DNA polymerase
yields PCR products with blunt ends, thereby reducing the error rates at the
fragment junctions.
• When using circular plasmid DNA as a template, it is important to use a
minimal amount of DNA (usually recommended 0.1–0.5 ng of plasmid
template per 50 µl PCR reaction) in order to reduce the template back-
ground after transformation. If higher amounts of plasmid template must
be used in PCR reaction or higher amounts of PCR product must be used
in the Gibson Assembly reaction, it is recommended to digest the PCR
product with DpnI restriction endonuclease in order to destroy plasmid
template before setting up the Gibson Assembly reaction (for protocol
see below).
• Verify PCR product purity and yield by gel electrophoresis. If non-specific
DNA fragments are obtained, you will need to purify the target fragment
from the agarose gel to ensure the correct product assembly during the
Gibson Assembly reaction.
• PCR product purification is not necessary as long as the product is
> 90% pure. You can add unpurified PCR product directly from the PCR
reaction into the Gibson Assembly for up to 20% of the total Gibson
Assembly reaction volume (i.e. PCR products should account for 4 µl, or
less, in a 20 µl Gibson Assembly reaction). Larger volumes of unpurified
PCR products could significantly inhibit both the Gibson Assembly and
the transformation. In such cases, it is recommended to column-purify
PCR products and, if necessary, to concentrate DNA by ethanol precipita-
tion.
Assembly Protocol:
1. Set up the following reaction on ice:
11
Chemically Competent Cells Transformation Protocol:
1. Thaw chemically competent cells on ice.
2. Transfer 50 μl of competent cells to a 1.5 ml microcentrifuge tube (if
necessary).
3. If the chemically competent cells are from New England Biolabs, add 2 µl
of assembled product to NEB competent cells and go to step 4 directly. If
competent cells are purchased from other manufacture, dilute assembled
products 4-fold with H2O prior transformation. This can be achieved by
mixing 5 µl of assembled products with 15 µl of H2O. Add 2 μl of the diluted
assembled product to competent cells.
4. Mix gently by pipetting up and down or flicking the tube 4–5 times. Do not
vortex. Place the mixture on ice for 30 minutes. Do not mix.
5. Heat shock at 42°C for 30 seconds.* Do not mix.
6. Transfer tubes on ice for 2 minutes.
7. Add 950 μl of room temperature SOC media* to tubes.
8. Place the tube at 37°C for 60 minutes. Shake vigorously (250 rpm) or rotate.
9. Warm selection plates to 37°C.
10. Spread 100 μl of the cells onto the plates with appropriate antibiotics. Use
Amp plates for positive control sample.
11. Incubate plates overnight at 37°C.
* Please note: Follow the manufacturer's protocols for the duration and
temperature of the heat shock step, as well as the optimal medium for
recovery. Typically, transformation of our positive control assembly product
will yield more than 100 colonies on an Amp plate with greater than 80%
colonies containing inserts.
12
6. Add 950 μl of room temperature SOC media to the cuvette immediately
after electroporation.
7. Place the tube at 37°C for 60 minutes. Shake vigorously (250 rpm) or
rotate.
8. Warm selection plates to 37°C.
9. Spread 100 μl of the cells onto the plates.
10. Incubate overnight at 37°C.
Usage Notes:
To ensure the successful assembly and subsequent transformation of
assembled DNAs, NEB recommends the following:
• Cells: Transformation efficiency of competent cells can vary by several logs.
Perceived assembly efficiency directly correlates to the competence of the
cells used for transformation.
• Electroporation: Electroporation can increase transformation efficiency by
several logs. When using the Gibson Assembly Master Mix product for
electroporation, it is necessary to dilute the reaction 3-fold and use 1 µl for
transformation.
• DNA: Purified DNA for assembly can be dissolved in ddH2O (Milli-Q® water
or equivalent is preferable), TE or other dilution buffers.
• Insert: When directly assembling fragments into a cloning vector, the
concentration of assembly fragments should be 2–3 times higher than
the concentration of vector. For assembly of 3 or more fragments, we
recommend using equilmolar ratio of fragments.
• Biology: Some DNA structures, including inverted and tandem repeats,
are selected against by E. coli. Some recombinant proteins are not well
tolerated by E. coli and can result in poor transformation or small colonies.
13
Frequently Asked Questions (FAQs):
What should I do if my assembly reaction yields no colonies, a small
number of colonies, or clones with the incorrect insert size following
transformation into E. coli?
Assemble and transform the positive control provided with the Gibson
Assembly Master Mix (see page 11,12). Successful assembly of a positive
control will demonstrate that the assembly mixture is functional and the
transformation conditions are suitable.
Analyze the reaction on an agarose gel. An efficient assembly reaction will
show assembled products of the correct size and the disappearance of
fragments.
Check the primer design of the overlapping DNA fragments to ensure that
there is sufficient overlap to facilitate assembly.
Consider whether the cloned insert may be toxic to E. coli and a low-copy
vector, such as a BAC, should be used. Because the assembled product is a
covalently closed molecule, it may be alternatively amplified by PCR or RCA.
14
How can I reduce the number of vector-only background colonies?
To significantly reduce the background of unwanted vector-only colonies,
the vector should be a PCR product rather than a restriction fragment. If
background continues to be a problem, the PCR-amplified vector can be
treated with DpnI to remove the template carry-over, if applicable, extracted
from an agarose gel following electrophoresis.
What are the shortest overlaps that can be used with this assembly
method?
Productive assembly has been shown for DNA fragments with as little as
12 bp overlap. However, it depends on the GC content of the overlap. We
recommend using 16 bp overlaps or more for dsDNA assembly with a Tm >
48°C (AT pair = 2°C and GC pair = 4°C).
What are the longest overlaps that can be used with this method?
The quantity of exonuclease in the Gibson Assembly Master Mix has been
optimized for the assembly of DNA molecules with ≤ 100-bp overlaps.
Can I use a 15-nt overlap that is entirely composed of His-tag repeats (i.e.
CACCACCACCACCAC)?
No, after the His-tag, you must include at least 3 nucleotides, that are not part
of the His-tag repeating sequence. Avoid repeating sequences at the end of an
overlap.
16
Are there any differences between the Gibson Assembly Master Mix (NEB
#E2611) and Gibson Assembly Master Mix included in the Gibson Assembly
Cloning Kit (NEB #E5510)?
The protocol for the Gibson Assembly Cloning Kit (NEB #E5510) is optimized
to perform one to two fragment assembly and cloning into a vector, while
the protocol for Gibson Assembly Master Mix (NEB #E2611) is optimized
to perform multiple-fragment assemblies (up to six fragments). The major
differences between the two protocols are the length of overlapping sequences
between the adjacent fragments and the incubation time of the assembly
reaction. The 15 minute assembly reaction protocol provided with the Gibson
Assembly Cloning Kit (NEB #E5510) is recommended for assembly of
fragments that are flanked by 15-25 nt overlaps. The Gibson Assembly Master
Mix (NEB #E2611) is recommended for assembly of up to six fragments that
are flanked by 20-80 nt overlaps, and requires a 60 minute reaction time.
Troubleshooting
Positive Control Yields No Colonies Following Transformation into E. coli
• Be sure to perform a positive control assembly reaction with 2X Gibson
Master Mix, followed by transformation using competent cells from (NEB
#C2987) as described on page 11,12. If competent cells are purchased
from other manufacture, dilute assembled products 4 times with H2O
prior transformation. This can be achieved by mixing 5 µl of assembled
products with 15 µl of H2O. Add 2 μl of the diluted assembled product to
competent cells.
• Competent cells may be thawed only once and cannot be repeatedly
frozen and thawed without extreme loss in competency. Cells are best
thawed on ice and DNA added as soon as the last bit of ice in the tube
disappears.
• Do not vortex competent cells. Mix cells and DNA by gently pipetting
up and down. Check cell competency by transforming 100 pg of pUC19
plasmid provided with the kit. Expect 1–3 x 109 colonies formed/μg DNA
after overnight incubation on LB-ampicilin plates at 37°C.
17
• Avoid overlaps with highly palindromic sequences as they may cause
up to a 10-fold reduction in recombinant colonies. When assembling
fragments into a multiple cloning site (MCS) of a cloning vector, it is
strongly recommended to use restriction sites that are located on the
edges of the MCS to avoid overlap regions with highly palindromic
sequences. Plate higher amounts of transformation reaction when using
restriction sites that are located in the middle of the MCS of the cloning
vector.
• Repeat the Gibson Assembly reaction using higher concentrations
of fragments and/or vector. Make sure that the total volume of PCR-
amplified products does not exceed 20% of Gibson Assembly reaction. If
necessary, purify PCR fragments and/or PCR-amplified vector before the
assembly reaction.
• Some DNA structures, including inverted and tandem repeats, are
selected against by E. coli. Some recombinant proteins are not well toler-
ated by E. coli and can result in poor transformation.
• Test the success of the Assembly by performing PCR with primers that
flank the assembled product.
• Consider whether the cloned insert may be toxic to E. coli, and a low-
copy vector, such as a BAC, should be used. Because the assembled
product is a covalently-closed molecule, it may be alternatively amplified
by PCR or rolling-circle amplification (RCA).
18
Gibson Assembly Reaction Yields a High Number of Clones
without the Insert
• PCR products may carry over large quantities of uncut plasmid template.
To remove plasmid template, treat PCR products with DpnI restriction
endonuclease before performing Gibson Assembly. Protocol for DpnI
digestion can be found on page 10.
• Restriction enzyme digested vector may carry over large quantities
of uncut plasmid. Some restriction enzymes do not cut supercoiled
plasmids to completion. The best way to reduce uncut vector background
is to digest the vector with two different restriction endonucleases. If a
single enzyme must be used, avoid restriction enzymes that leave four-
base single-stranded overhangs rich in C/G (i.e. CCGG overhang). These
overhangs may self-anneal to form the transformable form of the vector
molecule. Also, increase units and/or incubation time and/or purify the
linear vector from agarose gel.
References:
1. Gibson, D.G. et.al. (2009) Nature Methods, 343–345.
2. Gibson, D.G. et al. (2010) Nature Methods, 901–903.
For additional references and information on Gibson Assembly Master Mix, visit
www.syntheticgenomics.com. and www.jcvi.org.
19
Ordering Information
PRODUCT NEB # SIZE
Gibson Assembly Master Mix E2611S/L 10/50 reactions
COMPANION PRODUCTS
6 x 0.2 ml/
NEB 5-alpha Competent E. coli (High Efficiency) C2987I/H
20 x 0.05 ml
6 x 0.2 ml/
NEB 10-beta Competent E. coli (High Efficiency) C3019I/H
20 x 0.05 ml
20
21
DNA CLONING
DNA AMPLIFICATION & PCR
EPIGENETICS
RNA ANALYSIS
LIBRARY PREP FOR NEXT GEN SEQUENCING
PROTEIN EXPRESSION & ANALYSIS
CELLULAR ANALYSIS
USA France
New England Biolabs, Inc. New England Biolabs France
240 County Road Free Call: 0800/100 632
Ipswich, MA 01938-2723 Free Fax: 0800/100 610
Telephone: (978) 927-5054 e-mail: [email protected]
Toll Free: (USA Orders) 1-800-632-5227
Toll Free: (USA Tech) 1-800-632-7799 Germany
Fax: (978) 921-1350 New England Biolabs GmbH
e-mail: [email protected] Telephone: +49/(0)69/305 23140
www.neb.com Free Call: 0800/246 5227 (Germany)
Fax +49/(0)69/305 23149
Canada Free Fax: 0800/246 5229 (Germany)
New England Biolabs, Ltd. e-mail: [email protected]
Telephone: (905) 837-2234
Toll Free: 1-800-387-1095 Japan
Fax: (905) 837-2994 New England Biolabs Japan, Inc.
Fax Toll Free: 1-800-563-3789 Telephone: +81 (0)3 5669 6191
e-mail: [email protected] Fax +81 (0)3 5669 6192
e-mail: [email protected]
China, People’s Republic
New England Biolabs (Beijing), Ltd. United Kingdom
Telephone: 010-82378265/82378266 New England Biolabs (UK), Ltd.
Fax: 010-82378262 Telephone: (01462) 420616
e-mail: [email protected] Call Free: 0800 318486
Fax: (01462) 421057
Fax Free: 0800 435682
e-mail: [email protected]
Version 2.0
10/12